Alpha-heavy chain disease

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Jan 2025Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Wake Forest University Health Sciences

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Epogen

Amgen, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Epogen

(Epoetin alfa)Orphan drugstandard

Amgen, Inc.

12.1 Mechanism of Action Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Alpha-heavy chain disease.
Search all trials →
Search clinical trials for Alpha-heavy chain disease

Recent News & Research

No recent news articles indexed yet for Alpha-heavy chain disease.
Search PubMed for Alpha-heavy chain disease

Browse all Alpha-heavy chain disease news →

Specialist Network

Top 6 by expertise

View all Alpha-heavy chain disease specialists →

Quick Actions